Mental Illnesses Treatment Support & Programs NAMI Advocacy Find Your Local NAMI NAMIWalks
Search
 | Print this page | 
 | 
About_Research

Schizophrenia and Schizoaffective Disorder Research Studies


Is something missing from your schizophrenia treatment?

Date: February 27, 2014

While current schizophrenia medications often help control symptoms hallucinations, delusions, and paranoia, they don’t always help with cognitive impairments often noted in patients with schizophrenia, such as those associated with attention, memory, understanding, or reasoning.

As a result, local doctors are conducting a medical research study of an experimental drug that is taken along with a person’s current schizophrenia medication. In this study, they want to evaluate the safety and effectiveness of the experimental drug to see if it helps with cognitive impairments. Because the experimental drug will be an add-on drug to current treatment, you will continue taking your regular medication while in the study and will not be asked to change or stop taking this medication at any time.

To qualify for this study you must be:

  • 18-50 years of age
  • Medically diagnosed with schizophrenia for more than three years
  • Receiving a stable dose of an antipsychotic drug (other than clozapine) for at least 8 weeks prior to the study.

  • In a stable living situation and have someone who can provide information about you to study doctors and staff member.

All study-related visits, tests, and study drug will be provided to participants at no cost. In addition, reimbursement for study-related time and travel may be provided.

Comprehensive Clinical Development

11080 East Artesia Blvd., Suite #A, Cerritos, CA

562-965-3529

www.comprehensivecd.com


 

Do you have schizophrenia, schizophreniform, or schizoaffective disorder?

Date: January 10, 2014

A new research study at the University of Pittsburgh may be able to help with motivation, concentration, getting along with others, succeeding at school or work, organizing and planning, and managing stress. Eligible participants must be between the ages of 18 and 65, have schizophrenia, schizophreniform or schizoaffective disorder, diagnosed within the past 8 years, and are able to regularly visit the University of Pittsburgh. Participation in this research-based program is at no cost to the participant. Eligible participants may be selected to receive a new non-drug treatment for individuals with schizophrenia, schizophreniform or schizoaffective disorder. This treatment is based upon a previous program known as cognitive enhancement therapy. Involvement in this study will help researchers determine whether this experimental intervention will benefit those with this condition. Eligible participants will be compensated for any research assessments. For more information, contact Summer Kirven at 412-864-1626 or psychosisrecruiter@upmc.edu


Does computerized training help people with schizophrenia lessen their symptoms, learn new ways of thinking, and improve problem-solving skills?

Date: Updated April 8, 2014

Researchers at the Cognitive and Social Training (CAST) Program at the San Francisco Department of Veterans Affairs Medical Center (SFVAMC) are currently conducting a research study entitled “Optimizing Cognitive Remediation Outcomes in Schizophrenia”.

Altogether, you could receive up to $1820 for participating in this study!

Participants will be actively involved in the research study for approximately 20 weeks, with follow-up appointments 6, 12, and 24 months after completion. The exact length of participation will depend on how often you are available to complete the computer sessions.

We will perform a variety of computer and pencil-and-paper tasks that assess various aspects of thinking and problem-solving. These tests will be given on several occasions. Additionally, blood samples will be taken at each evaluation to assess for hormonal factors. All assessments will be conducted at the SFVAMC at no cost to the participant.

Additionally, there is an option of participating in the computerized training portion of the study remotely. Participants will be given an iPad to perform computerized training at home.

How can a participant qualify for the study? Participants should:

  • Have a diagnosis of schizophrenia or schizoaffective disorder.
  • Be in good general health.
  • Be an outpatient
  • Be on stable medication
  • Speak English as their first language
  • Have no metal in their body
  • Live in the San Francisco Bay Area

Interested? Please contact San Francisco Department of Veterans Affairs Medical Center (415) 221-4810 x3077.



Study on Salsalate as an Adjunctive Treatment in Schizophrenia

Date: September 13, 2013

The Psychotic Disorders Research Program at UMass Medical School in Worcester, MA is currently running an NIH-funded study entitled Salsalate as an Adjunctive Treatment in Patients with Schizophrenia.

This is an open-label 12-week pilot research study examining how salsalate, an anti-inflammatory drug, affects positive and negative symptoms of schizophrenia, Hemoglobin A1c, fasting glucose, other metabolic issues and cognitive functioning when added to an antipsychotic medication. We are seeking your help to recruit eligible subjects.

Inlucsion Criteria:

  • Age 18-65
  • Diagnosis of schizophrenia or schizoaffective disorder
  • Meets diagnostic criteria for current alcohol abuse or dependence
  • Currently on a stable dose of antipsychotic medication (for at least one month)

Exlucsion Criteria:

  • Current substance abuse
  • Significant medical illnesses including uncontrolled hypertension, diabetes, seizure disorder, severe cardiovascular, cerebrovascular, pulmonary or thyroid diseases.
  • Currently on immunosuppressant medication including oral steroids.
  • Use of anti-coagulants.

People in the study will be compensated for their time.

All information is kept private.

Enrollment Information:

For more information contact Radhika Natara at 508-856-8323 or email Radhika.Natarajan@umassmed.edu.



Study on Alcohol Abuse and Schizophrenia

Date: September 13, 2013

The Psychotic Disorders Research Program at UMass Medical School in Worcester, MA is running an NIH-funded study to investigate whether the combination of risperidone and desipramine is effective in reducing alcohol consumption in individuals suffering from schizophrenia and ongoing alcohol drinking. Below are the major inclusion and exclusion criteria

Inlucsion Criteria:

  • Age 18-65
  • Suffers from schizophrenia or schizoaffective disorder
  • Meets diagnostic criteria for current alcohol abuse or dependence

Exlucsion Criteria:

  • Suffers from any substance abuse disorder other than caffeine, nicotine, and cannabinoid containing substances
  • Continues to use alcohol despite treatment with medications such as naltrexone, acamprosate, disulfiram, topiramate, etc.

People in the study will be compensated for their time.

All information is kept private.

Enrollment Information:

For more information contact Matthew Goodnow at 508-856-2494 or email Matthew.Goodnow@umassmed.edu.



A Research Study on Treatment of Marijuana Use and Schizophrenia

Date: September 13, 2013

Researchers at the Psychotic Disorders Research Program in the Department of Psychiatry at UMass Medical School in Worcester, MA are looking for volunteers for an NIH-funded research study involving schizophrenia and marijuana use.

We are studying whether an FDA-approved drug, clozapine, can reduce marijuana use in individuals who suffer from schizophrenia and ongoing marijuana use.

Inlucsion Criteria:

  • Age 18-55
  • Suffers from schizophrenia or schizoaffective disorder
  • Meets diagnostic criteria for marijuana abuse or dependence.

Exlucsion Criteria:

  • Suffers from any substance abuse disorder other than caffeine, nicotine, and alcohol abuse disorder
  • Currently receives treatment with clozapine or risperidone, or suffers from a medical condition in which treatment with clozapine or risperidone would be impractical or unsafe

People in the study will be compensated for their time.

All information is kept private.

Enrollment Information:

If you are interested and would like more information, please call Radhika Natarajan at 508-856-8323 or email Radhika.Natarajan@umassmed.edu.



Looking for Adults, 18-30, who have a sibling with schizophrenia for research study

Date: September 13, 2013

I am a doctoral social work student who is conducting a study about the experiences of emerging adult siblings of people with schizophrenia. I am looking for adults from the age of 18-30 of people with schizophrenia to conduct one interview that will last approximately an hour and a half. I can either interview in person at a mutually agreed upon site or conduct telephone or Skype interviews which will be then recorded and transcribed.

The focus of the study is to better understand the experiences of emerging adult siblings’ of people with schizophrenia, particularly considering how sibling relationships influence identity formation. Questions about family, relationships, vocational and educational experiences and personal values will be included.

To be included in the study, the interviewees need to be 18 to 30 and have a sibling with whom they lived for at least five years and whom they share at least one biological parent. Their sibling needs to be diagnosed with Schizophrenia, Schizoaffective disorder or another form of Schizophreniform Disorder. Participants with Psychotic Disorders are excluded from the sample because of the parameters of the studies. However, people with other psychiatric diagnoses are included.

This study is voluntary. Participants can leave the study at any time, including after they have already completed an interview. Names, geographic location and other compelling identifying information will be removed from the study. Participants will be able to discuss and read the findings with the researcher when the study is completed. Each participant will receive nominal compensation for their time ($25 gift certificate).

Enrollment Information:

If you are interested in participating, please call Jillian Graves, LCSW at 617-335-9178 or email jgraves@brynmawr.edu.




Living with schizophrenia (or schizoaffective disorder) and experiencing involuntary movements?

Date: April 18, 2013

If so, you’re invited to see if you may qualify for a medical research study to determine if an investigational drug may help you manage your involuntary movements.

To learn more, visit www.KinectStudy.com.


Participate in Research: Schizophrenia and the Family

Date: April 18, 2013

My name is Rachel Morton from the School of Psychology and Counselling at the Queensland University of Technology. I’m researching the experience of family members who have lived with or are living with a close family member who has been diagnosed with schizophrenia. I would like to know what you do to cope with stress, your own personal characteristics, including some questions about your medical history, your levels of stress and any potential benefits.

We are looking for:

  • First degree family members (eg. parents, siblings or children) of those diagnosed with schizophrenia (aged 16 and over)
  • Who have lived with your relative at some point since their diagnosis

Participation involves:

  • Completing an online questionnaire package about your experiences of living with someone who has schizophrenia. Your participation is expected to take 20-25 minutes.

Participants will have the opportunity to enter into a draw upon completion receive one of two $50 shopping vouchers.

If you are ready to participate now please go to this link for more information and to complete the survey, http://survey.qut.edu.au/f/175766/c9eb/

Many thanks for your consideration of this request.

If you or a loved one suffer from schizophrenia, schizoaffective disorder, bipolar disorder, or a gastrointestinal disorder and are experiencing involuntarymovements in your face or other parts of your body, you may qualify for a medical research study.

Date: April 18, 2013

If you have schizophrenia, schizoaffective disorder, bipolar disorder, or a gastrointestinal disorder (including trouble with reflux and/or gastric emptying) and experience symptoms of tardive dyskinesia, you’re invited to see if you may qualify for a clinical research study to determine if an investigational drug may help you manage your involuntarymovements.

Each individual must be 18 to 85 years of age, and will be evaluated to determine eligibility. All participants will receive study-related medical exams and lab tests at no charge. Compensation for time and travel may be available.

To learn more, visit www.Kinect2Study.com.

Have You Been Diagnosed With Schizophrenia?

Date: March 5, 2013

If you have been diagnosed with schizophrenia, you may qualify to participate in a clinical research study with an investigational medication for schizophrenia being conducted by Comprehensive Clinical Development.

Qualified participants between ages 18 to 65 will receive, at no cost, all study related care including:

  • Psychiatric evaluations
  • Study related medical care and
  • Study medication

You may be compensated for time and travel during participation and insurance is not needed.

Call Comprehensive Clinical Development at 727-576-8474 to see if you may qualify or for more information or visit website at www.comprehensivecd.com.


“Gating and Inhibition in Schizophrenia,” Principal Investigator: Dr. David L. Braff

Location: San Diego, California

Age: 18-65

Date: February 28, 2013

Researchers from the University of California, San Diego, in the Department of Psychiatry need men and women ages 18 – 65 with a diagnosis of schizophrenia for a research study investigating how the brain processes information.

Participation will include:

  • A brief interview about your medical & psychiatric history
  • Completion of a series of problem-solving tests
  • Measurements of your eye blinks and brainwaves
  • Recordings of your eye movements
  • You will be compensated $10 per hour for your time
  • Testing may last 1 to 7 hours

Persons Eligible:

  • Males or Females between ages 18-65
  • Have a diagnosis of schizophrenia

Persons NOT Eligible:

  • Current substance abuse
  • Significant, unstable medical illness

If you are interested in participating please call Natalie or Lauren at (619) 543-7201 or email nmccarthy@ucsd.edu


Emotion in Schizophrenia and Bipolar Disorder

A VA Greater LA Healthcare System & UCLA study - Principal Investigator, William P. Horan, Ph.D

Date: February 28, 2013

What is this study about?

  • The purpose of this research study is to understand how the brain functions when processing emotional information in people with schizophrenia or bipolar disorder. The study will involve electroencephalography (EEG) and psychophysiological techniques to obtain images of brain activity involved in processing emotional information.

Who is eligible?

  • We are looking for people who have a diagnosis of schizophrenia or bipolar disorder. In addition, you must be 18-60 years of age, not have a significant neurological condition (i.e. epilepsy, multiple sclerosis, etc.), have no history of serious head injury, and no evidence of drug or alcohol abuse in the past 6 months, and no metal or medical implants in the body.

What do you have to do?

  • You may be asked questions about your personal history
  • You may be asked to perform emotional processing and decision making tasks while EEG equipment records electrical activity in your brain
  • You will be asked to perform a picture viewing task that will include images that might be experienced as scary, disturbing, or uncomfortable
What do you receive?
  • There is no medical benefit to you for participation. You will receive compensation for participation, parking, and travel.

How long does it take?

  • The interview will last approximately 1 hour and 45 minutes
  • The EEG procedures will be from 2 to 3 hours

What are the risks?

  • The EEG recording involves remaining still in a seated position, so you may feel uncomfortable
  • You may experience some slight discomfort on your scalp from the EEG recording equipment
  • Some picture may make you feel uncomfortable

What do you receive?

  • There is no medical benefit to you for participation. You will receive compensation for participation, parking, and travel.

Please contact Amanda Bender, MS 310-478-3711 ext. 41527 for more information


Medication Study for Weight Loss and Cognitive Improvement in Schizophrenia

Date: Oct. 6, 2011

Location: Boston, Massachusetts
Age: 18-65

Have you been diagnosed with schizophrenia or schizoaffective disorder?

Are you currently taking clozapine or olanzapine (Zyprexa)?

“Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients with Schizophrenia,” Principal Investigator: Dr. Xiaoduo Fan.

Researchers from the Massachusetts General Hospital, Psychiatry Department seek men and women ages 18-65 that have a diagnosis of schizophrenia or schizoaffective disorder and are treated with clozapine or olanzapine antipsychotic medications. This twelve-week research study examines the effects of telmisartan, a hypertension medication, on insulin resistance, body composition and symptoms of schizophrenia when added to a treatment of clozapine or olanzapine. We are interested in learning whether telmisartan improves how the body manages insulin levels, decreases waist circumference and stomach fat, and thereby decreases the risk of diabetes and cardiovascular disease. Participants are compensated up to $205.

Persons Eligible:

  • Males or Females between ages 18-65
  • Have a diagnosis of schizophrenia or schizoaffective disorder
  • Currently taking clozaril (Clozapine) or olanzapine (Zyprexa)

Persons NOT Eligible:

  • Current substance abuse
  • Treatment with insulin, spironolactone, diboxin, warfarin or diuretics
  • Significant, unstable medical illness

Enrollment Information:
If you are interested in participating or would like to make a referral, please call Claire Oppenheim at (617) 912-7837 or email coppenheim@partners.org.

Do you have a parent, child or sibling living with schizophrenia, schizoaffective disorder, or bipolar disorder?

Age: 18+
Location: By telephone, web or email.

If you answered "yes", we would love to hear from you! We are UBC researchers who have developed a questionnaire to help measure internalized stigma in first-degree relatives of people living with a severe mental illness.

What is the purpose of the research?

Stigma affects individuals living with a mental illness and their family members. The purpose of this study is to validate a questionnaire that we have recently developed to measure internalized stigma in first-degree family members (parents, brothers, sisters, and children) of people with schizophrenia, bipolar disorder, or schizoaffective disorder. The questionnaire will be used to gather information about how family members of people living with mental illness experience stigma, which can also be helpful in evaluating the well being of family members. Later on, the questionnaire will also be used in the development and evaluation of strategies to reduce individuals’ internalized stigma.

Who can participate?

Parents, siblings, and children of people living with schizophrenia, schizoaffective disorder, or bipolar disorder. We are looking for both men and women to participate in this study.

What is involved in participating?

If you participate in this study you will be asked to complete questionnaires at two time points that are one month apart. The questionnaires include the new stigma questionnaire as well as seven other questionnaires (that ask about things like self-esteem and mood).

You do not have to travel to participate in this study; you can participate entirely from home by telephone and mail or email.

Each time point should take approximately 30 to 45 minutes of your time to complete.

How do I participate?

If you are interested in participating, please contact the Research Coordinator (Emily) at: (604) 875-2000 x4732 or by email at mental.illness@ubc.ca

Posted: August 10, 2010


Schizophrenia and Bipolar Disorder Family Genetic Research Study

Age: 15-65
Location: Chicago

The University of Chicago along with the University of Illinois at Chicago are seeking individuals in the Chicago area who live with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder with psychotic features with available immediate family members to participate in our genetic study.  Family members do not have to have mental health symptoms to participate.  The overall goal of this research is to improve our understanding about the biological causes of these illnesses so that we can develop better treatments to improve and eventually restore the lives of patients who live with them.  This study is overseen at the University of Chicago by investigator Dr. Elliot Gershon and Principal Investigator Dr. John Sweeney at the University of Illinois at Chicago.

Participants will undergo a 2-4 hour diagnostic interview at the University of Chicago , and then several physiological tests which take eight or more hours to complete at the University of Illinois at Chicago. Physiological tests include a urine screen, blood sample, eye movement assessments, cognitive assessment, EEG, and an MRI.  Each participant will be reimbursed per assessment (maximum reimbursement per participant is $190). Participation is subject to eligibility.  There is no expense to the subject to participate.  The study is on-going until 2012.

Contact the study line at 866-51-GENES or 773-834-3560 for more information. More information is provided on our website:   http://www.ucfamily.org/familystudies/main.html.

Posted: 1 September 2009


NIMH Genetic Study of Schizophrenia Protocol # 95-M-0150

The Schizophrenia Research Program at the National Institute of Mental Health located at on the campus of the National Institutes of Health in Bethesda, Maryland, is seeking healthy adults diagnosed with schizophrenia or schizoaffective disorder (depressed type) to participate in a two-day outpatient study. Travel and lodging assistance is provided and a stipend is also given to participants. This study seeks to identify the genetic and environmental factors that increase the risk of developing schizophrenia. The procedures include confidential interviews and a blood draw, a neurological exam and neuropsychological testing, neuroimaging, and recordings of brain waves. Siblings are also invited to participate in these procedures and parents are invited to give a sample of blood if possible. For more details, call the toll-free schizophrenia studies referral line at 1-888-674-6464 (TTY: 866-411-1010) at NIH, Department of Health & Human Services.


NIMH Seeks Volunteers for Six-Month Schizophrenia Study

The Schizophrenia Research Program at the National Institute of Mental Health specializes in the field of schizophrenia and is conducting a six-month inpatient research study of the neurobiological causes of schizophrenia at the National Institutes of Health in Bethesda, Maryland. The program involves extensive psychological, psychiatric, neurological, and medical evaluations, and neuroimaging. Study participation involves a period of time without medications. Throughout their stay in the research program, participants receive expert, personalized care, and are encouraged to participate in the clinical milieu that provides educational programs, recreational and occupational therapy, and art and music therapies. Participants must be between the ages of 18 and 50, be diagnosed with schizophrenia or schizoaffective disorder, and be free of significant medical/neurological illnesses and active substance abuse. There is no charge to participate. For more details, call the schizophrenia research referral line at 1-888-674-6464, (TTY: 866-411-1010) at NIH, Department of Health & Human Services.


Schizophrenia and Bipolar Disorder Family Genetic Research Study

Location: Maryland
Age: 15-65

The Maryland Psychiatric Research Centerat the University of Maryland School of Medicine is currently conducting a NIMH funded study on the genetic causes of Schizophrenia and Bipolar disorder. The purpose of the study is discover how the genetic risk for these illnesses and their associated biological and behavioral traits is transmitted in families.

You may be eligible to participate in the study if you meet these conditions:

  • Age between 15-65 years
  • Diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder (with psychosis)
  • Have at least one biological first-degree relative, i.e., a sister, brother, mother or father willing to participate. The relative does not need to be diagnosed with a psychiatric disorder but it is ok if they are
  • No serious medical, neuro-opthalmological or neurological illness (e.g., cancer, seizure disorders, encephalopathy)
  • No current substance abuse (within past 3 months) or past history of substance dependence (within 6 months or extensive history)
  • No ferromagnetic objects lodged in the body

Participation involves:

  • Clinical interviews to evaluate diagnosis and gather other personal information
  • Neuropsychological Tests to examine thinking abilities such as attention and memory
  • Electroencephalography (EEG)/Sensory Gating tests to measure brain activity in response to sounds
  • Eyetracking tests to measure eye movements and visual attention
  • MRI to measure brain structures and function
  • Blood sample for DNA (genetic) studies
  • Urine sample to screen for drugs and pregnancy

The total amount of time it takes to complete the study is approximately 14-16 hours. Transportation can be provided if needed. All participants will be compensated for their time.

For more details, call our research coordinator, Jennifer Jones, at 410-402-6823

Posted: April 15, 2009


Cognitive-Behavior Therapy (CBT) for Psychosis Study

Age: 18-45
Location: Columbia University and The New York State Psychiatric Institute, New York, NY.
Study End Date: 2012

This study examines the impact of Cognitive-Behavior Therapy (CBT) on symptoms, physiological arousal, stressors, and the ways to deal with them in individuals with schizophrenia. The primary aim of this study is to investigate the role cognitive coping strategies play in mediating the link between stress, physiological arousal and psychotic symptoms in individuals with schizophrenia during recovery from psychosis.

Study Design: Participants will be randomized to receive either standard psychiatric treatment or up to 26 weekly sessions of individual CBT to target hallucinations and/or delusions in addition to standard psychiatric treatment. All participants may continue to receive treatment from their current psychiatrist during the study. Participants will complete research assessments at the beginning of the study and after 10, 20, and 30 weeks. These will include interviews, questionnaires, and neuropsychological tests, as well as monitoring sessions of heart rate and experiences. For more information, please see   http://clinicaltrials.gov/show/NCT00791440.

Persons eligible:

  • Males or females between ages 18-45.
  • English speaking.
  • Have a diagnosis of schizophrenia, or schizoaffective disorder, or schizophreniform disorder.
  • Experience frequent hallucinations or delusions (for example: suspicious thoughts, and/or hear voices that other people can’t hear, and/or see things that other people can’t see).

Persons Not Eligible:

  • Have a history of heart problems or hypertension.
  • Is using regularly any medications for heart problems or hypertension.
  • Have used street drugs within the past 4 weeks.
  • Have history of having active suicidal plans or serious self-destructive, violent or aggressive behavior during the past 5 years.
  • Have history of neurological disorders or medical conditions known to seriously affect the brain.

Payment:The CBT treatment is provided free of charge. Participants may receive up to $350 (over ~7 months) for completing the four research assessments including the interviews, questionnaires, neuropsychological tests, monitoring sessions of heart rate and experiences, and providing two urine samples. 

Contact:                      David Kimhy, Ph.D.
Contact Information: (212) 543-6817 or kimhyda@pi.cpmc.columbia.edu

Posted: March 27, 2009


Have You Ever Been Diagnosed with Schizophrenia?

Age: 18-90
Location:
Ohio

You may be able to participate in a research study to better understand schizophrenia.

  • You must be between the ages of 18 and 90,
  • You will be asked to complete a brief questionnaire, a discussion of your health history, and provide a small blood sample, and 
  • You will receive compensation for your time and travel if you complete the study.

For more information, or to make an appointment, please call Brandi Palmer, MS, PC or Douglas Lehrer, MD at 937-395-8227.

The Boonshoft Schizophrenia Center, The Wallace-Kettering Neuroscience Institute at Kettering Medical Center

Posted: March 4, 2009


Are You Currently Employed in Volunteer or Paid Employment and Have a Diagnosis of Schizophrenia or Psychotic Disorder?

Age: 18+
Location: Web survey

My name is Jenessa Fisk. I am a graduate student in Occupational Therapy at Ithaca College in Ithaca, NY. I am currently working on my thesis project, which will explore reasons why people with schizophrenia and psychotic disorder work and why they are able to work. I am looking for individuals who are over the age of 18, have a diagnosis of schizophrenia or psychotic disorder, and are currently employed in volunteer or paid employment.

The results will be used to guide how occupational therapists and other rehabilitation specialists can work with individuals with schizophrenia and other psychotic disorders to find and keep a job (paid or volunteer). To view and participate in the online survey, please click the link below. If the link does not directly connect you to the survey, please copy and paste it into your web browser.

https://www.surveymonkey.com/s.aspx?sm=7Fuq4_2b1mKsFKRy73dfNU7A_3d_3d

If you have any questions about the survey or being a participant, please contact me at jfisk1@ithaca.edu or contact Dr. Judy Gonyea, my thesis advisor, at (607) 274-1737 or jgonyea@ithaca.edu.

All information will remain confidential.

Thank you.

Posted: February 17, 2009


Seeking persons with persistent auditory hallucinations or voices for TMS clinical trial in New Haven CT

Age: 18-55
Location: New Haven, CT

Investigational treatment for persons with auditory hallucinations ("voices") using Transcranial Magnetic Stimulation is being studied at Yale School of Medicine. We are seeking participants who:

  • hear "voices" at least 3-4 times per day;
  • are between ages 18-55;
  • do not have a significant neurological condition such as epilepsy. 

Study duration is 4-8 weeks.  Reasonable transportation costs to and from New Haven are covered from anywhere within the US Participants are admitted to an inpatient research unit and remain on their psychiatric medications.  Subject payment is $400. For further information contact Ralph Hoffman MD (203-688-9734) or Joan Nye (203-737-2762).   Approved by the Yale Human Investigation Committee (#27023).

Posted: February 17, 2009


Schizophrenia… It Can Decrease Your memory and Thinking Ability   

Age: 18-55
Location: New Jersey

Have you been diagnosed with schizophrenia? Are you currently being treated with a stable dose of Seroquel ®, Zyprexa ®, Risperdal ®, or Abilify ®?

If so, and you are 18-55, you may qualify to participate in a research study to learn about the effects of an investigational drug on cognitive function in individuals with stable schizophrenia. Qualified participants may receive at no cost study-related:

  • Psychiatric evaluations
  • Study drug
  • Follow-up visits
  • Compensation for time and travel

Contact: Center for Emotional Fitness, Cherry Hill , NJ , 866-548-2333 (Extension 21)

Posted: February 17, 2009


Are you or is someone you know being treated for Schizophrenia?

Location: Boston, MA

The MGH Schizophrenia Program has several research opportunities in the areas of genetics, health and weight management, brain imaging and new treatments: both psychological and medical.

Compensation for time & transportation provided.

Please call us at: 617-912-7828.

Principal Investigator  - Donald Goff, MD

Posted: 14 October, 2008


Genetic Study of Schizophrenia

Age: 18-70
Location: Boston, MA

The Massachusetts General Hospital Schizophrenia Program is conducting a research study to better understand the genes involved in the symptoms of schizophrenia. We are seeking volunteers diagnosed with schizophrenia ages 18 to 70. The study involves one three-hour visit which includes a blood draw for four tubes of blood and a series of interviews and cognitive (thinking processes) testing. If you wish, your psychiatrist may receive a report of the cognitive test results. Payment of $30 is provided for participation. Transportation reimbursement is available. Please contact Kelsey at 617-912-7868 or via e-mail at kshannahan@partners.org  if you are interested in learning more about this study.

Posted: 14 October, 2008


Are you being treated for schizophrenia or schizoaffective disorder?

Age: 18-65
Location: Boston: MA

The Schizophrenia Program at the Massachusetts General Hospital- Freedom Trail Clinic is conducting an open-label trial comparing the effectiveness of the long-acting antipsychotic medication, risperidone microspheres (Consta), to a clinician's choice of second generation oral antipsychotic medications. We are seeking patients 18-65 years old diagnosed with schizophrenia or schizoaffective disorder who continue to remain symptomatic or have been admitted to a hospital within the past 12 months. All medications are FDA approved and currently used in clinical practice. The study is up to 30 months long with biweekly visits.

Antipsychotic medication (Consta or oral second generation) is provided free of charge during participation. Remuneration will be up to $800 with an average remuneration of $160 every 6 months. Transportation reimbursement is available.

Please contact Jared Walsh at (617) 912-7864 or via e-mail at jpwalsh@partners.org if you are interested in the study.

Posted: 14 October, 2008


Are you being treated for schizophrenia?

Age: 18-68
Location: Boston, MA

The Schizophrenia Program at the Massachusetts General Hospital- Freedom Trail Clinic is conducting a research trial to test the effectiveness of the vitamins Folate and B12 for treating symptoms of schizophrenia. Subjects will be randomly assigned, by chance, to receive either the study vitamins or placebo (contains no active vitamin). We are seeking patients 18-68 years old diagnosed with schizophrenia who continue to remain symptomatic despite treatment with medication. The study is 19 weeks long with biweekly visits. The vitamins used in this study are provided free of charge during participation. Remuneration will be up to $195 with the possibility of earning an additional $400 for participating in the optional imaging procedures. Transportation reimbursement is available. Please contact Hope McChesney at (617) 912-7863 or via e-mail at hmcchesney@partners.org if you are interested in the study.

Posted: 14 October, 2008



Medication Study of Learning and Memory in Schizophrenia

Age: 18-60
Location: Boston, MA

The Massachusetts General Hospital Schizophrenia Program is conducting a research study to compare the effects of an investigational medication (MK-0777) versus placebo (contains no active medication) on attention, learning and memory. We are seeking volunteers diagnosed with schizophrenia ages 18 to 60 who are currently taking one of the following medications: risperidone, risperidone microspheres, aripiprazole, olanzapine, ziprasidone or quetiapine. The study involves taking either the study medication or the placebo for a total of 6 weeks. Neither you nor your clinician will know if you are taking the active drug or the placebo during the study. There will be 10 visits over a period of 8 weeks, with additional follow up at 6 and 12 months. Remuneration of up to $180 will be provided. Transportation reimbursement is available. Please contact Jared at 617-912-7864 or via e-mail at jpwalsh@partners.org if you are interested in learning more about this study. 

Posted: 14 October, 2008

 


Are you currently taking or considering taking Geodon for the treatment of schizophrenia or schizoaffective disorder?

Age: 18-65
Location: Boston, MA

The Schizophrenia Program at the Massachusetts General Hospital- Freedom Trail Clinic is conducting a research trial to assess whether Geodon dose escalation (meaning a dose of Geodon higher than is typically used) improves symptoms of schizophrenia compared to continued standard treatment. Subjects taking Geodon 160mg/day will be randomized (that is, assigned by chance, like the flip of a coin) to receive additional treatment up to 320mg/day of Geodon or placebo (looks like the study drug, but contains no active medication). We are seeking patients 18-65 years old diagnosed with schizophrenia or schizoaffective disorder who continue to remain symptomatic despite treatment.

Geodon is an FDA-approved medication for the treatment of schizophrenia and schizoaffective disorder. Patients who are not currently taking 160mg/day can participate in an open-label phase (meaning that the subject will be taking active medication and will be aware of that) to reach the appropriate dose required for screening. Study medication is provided free of charge during the study and subjects will receive remuneration up to $175. Reimbursement for transportation expenses is available. Please contact Jared Walsh at (617) 912-7864 or via e-mail at jpwalsh@partners.org if you are interested in the study.

Posted: 14 October, 2008


ARE YOU TAKING ONLY ONE OF THE FOLLOWING: RISPERDAL, OLANZAPINE, SEROQUEL, ABILIFY AND EXPERIENCING ANY COGNITIVE IMPAIRMENT?

Age: 18-65
Study Location:
San Diego

COGNITIVE IMPAIRMENTS INCLUDE:

- deficits in areas such as memory, attention, planning, and problem solving
- problems with verbal and visual learning
- having a hard time managing emotions

Medical researchers at UCSD are currently conducting a clinical research study to evaluate an investigational drug for the cognitive impairment in schizophrenia.

Participants must be between 18 and 65 years of age to be eligible.

Medical and psychological evaluations and study drug will be provided at no cost. Eligible participants will also receive reimbursement for time and travel.

For more information please call:
(866)550-UCSD
UCSD Department of Psychiatry


VOLUNTEERS NEEDED FOR RESEARCH

Study Location: San Francisco
Age: 18+

  • Have you been given the diagnosis of schizophrenia by a mental health professional?
  • Are you at least 18 years old?
  • Have you not experienced severe symptoms for at least 6 months?

Hello, my name is Nisha Fernandes, I’m an advanced graduate student at the California School of Professional Psychology, San Francisco, and I’m currently seeking volunteers for my research about the experience of self in schizophrenia.

I want to have a deep understanding of schizophrenia and its’ process so that  I, and other clinicians may eventually learn how to effectively treat this phenomenon.   In order for me to truly understand the experience of self in schizophrenia, I wish to talk with individuals who have gone through this process.

Interested persons will be asked to participate in a brief phone interview to determine if my study is a good fit for you, and if you meet criteria for my study.  If you are eligible for my study, you will be invited to 2 confidential, individual interviews of up to 1.5 to 2.0 hours each at a mutually agreed upon location (my school, a park, coffee shop, etc.)

Volunteers who share their experience with me, by participating in my study, may find that it helps develop their own understanding of what they went through.  It can also feel good to know that you are doing something that may eventually help others who are going through and will go through similar experiences with schizophrenia.  Also, as a thank you for participating in my study, I will give you $50 at the end of the second interview.

If you are interested in volunteering, or have any questions at all about my study, please call (415) 519-2593 or email me StudyOnSelf@yahoo.com.

Posted: 8 April, 2008


Read More About Research


 | Print this page | 
 | 

Donate

Support NAMI to help millions of Americans who face mental illness every day.

Donate today

Speak Out

Inspire others with your message of hope. Show others they are not alone.

Share your story

Get Involved

Become an advocate. Register on NAMI.org to keep up with NAMI news and events.

Join NAMI Today
  • Follow NAMI
  • Contact Us
    • NAMI
    • 3803 N. Fairfax Dr., Suite 100
    • Arlington, Va 22203
    • Main: (703) 524-7600
    • Fax: (703) 524-9094
    • Member Services: (888) 999-6264
    • Helpline: (800) 950-6264